• Product information

  • Opdivo (nivolumab)

  • Yervoy (ipilimumab)

  • Opdualag (nivolumab + relatllimab)

oncall-logo
My Dashboard
Indications
Melanoma
Melanoma Highlights
MET Opdivo + Yervoy
Metastatic Opdualag
Adjuvant Opdivo
Melanoma Materials
Genitourinary cancers
Genitourinary Highlights
RCC
MIUC
Metastatic UC
Genitourinary Materials
Genitourinary Case Studies
Gastrointestinal Cancers
Gastro-oesophageal Highlights
GC/GOJC/OAC
OSCC
Gastro-oesophageal Materials
Thoracic cancers
Thoracic Highlights
Early Stage NSCLC
Metastatic NSCLC
Mesothelioma
Thoracic Materials
Thoracic Case Studies
Met-nsclc-ros1-postive
Resources
Patient Resources
PBS Codes & Dosing Information
irAR Management
Melanoma Treatment Sequencing Tool
Anatomy Aide
Materials Catalogue
EVIQ
Request a rep
My Profile Log out
image
Results of your search
Loading
No results found
0 Results
Clear Filter
Sort by Date
You might also be interested in
/content/buildeasy/apac-commercial/oncall-hcp-au/en.html /content/dam/buildeasy/apac-commercial/oncall-hcp-au/en/documents.html

foot note heading

BACK TO TOP

My Account

Contact us

Legal Notice

Privacy Policy

Modern Slavery Statement

© 2026 Bristol-Myers Squibb.

Bristol-Myers Squibb Australia Pty Ltd, ABN 33 004 333 322, 4 Nexus Court, Mulgrave, VIC 3170.